title: Radiotherapy and chemotherapy in pancreatic cancer. Topical issues and future perspectives.
authors.affiliation: Department of Radiotherapy, CRO, Aviano (PN), Italy. gboz.rt.cro@cro.it
authors.forename: Giovanni
authors.initials: G
authors.lastname: Boz
authors.forename: Antonino
authors.initials: A
authors.lastname: De Paoli
authors.forename: Roberto
authors.initials: R
authors.lastname: Innocente
authors.forename: Carlo
authors.initials: C
authors.lastname: Rossi
authors.forename: Gian Carlo
authors.initials: GC
authors.lastname: Tosolini
authors.forename: Claudio
authors.initials: C
authors.lastname: Bassi
authors.forename: Massimo
authors.initials: M
authors.lastname: Falconi
authors.forename: Paolo
authors.initials: P
authors.lastname: Pederzoli
authors.forename: Mauro G
authors.initials: MG
authors.lastname: Trovò
mesh_terms: D017024:Chemotherapy, Adjuvant / Q000379:methods; D002945:Cisplatin / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D003841:Deoxycytidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D010190:Pancreatic Neoplasms / Q000188:drug therapy* / Q000209:etiology / Q000401:mortality / Q000532:radiotherapy*; D018714:Radiotherapy, Adjuvant / Q000379:methods; D011881:Radiotherapy, Computer-Assisted / Q000379:methods; D015996:Survival Rate; D000093542:Gemcitabine
chemical_list: D007166:Immunosuppressive Agents; D003841:Deoxycytidine; D002945:Cisplatin; D005472:Fluorouracil; D000093542:Gemcitabine